For in vitro diagnostic use. Others Elecsys AMH Plus IVD Elecsys® AMH Plus CPS_000433 07957190190 AMH Plus Elecsys cobas e 100 Elecsys AMH Plus 07613336103166 Reagents, kits 100 tests cobas e 411/601/602 true 08818061190 AMH plus Elecsys cobas e 100 V2 Elecsys AMH Plus 07613336166222 Reagents, kits 100 tests cobas e 411/601/602 true 10059524190 AMH plus Elecsys E2G 100 V3 Elecsys AMH Plus 07613336226483 Reagents, kits 100 tests cobas e 402/801 true 10059516190 AMH plus Elecsys cobas e 100 V3 Elecsys AMH Plus 07613336226476 Reagents, kits 100 tests cobas e 411/601/602 true 08818916214 AMH plus Elecsys E2G 100 V2 AMH plus Elecsys E2G 100 V2 07613336223505 Reagents, kits 100 tests cobas e 402/801 true 08818916190 AMH plus Elecsys E2G 100 V2 Elecsys AMH Plus 07613336166246 Reagents, kits 100 tests cobas e 402/801 true 08818916188 AMH plus Elecsys E2G 100 V2 AMH plus Elecsys E2G 100 V2 07613336223499 Reagents, kits 100 tests cobas e 402/801 true 07957246190 AMH Plus Elecsys E2G 100 Elecsys AMH Plus 07613336103159 Reagents, kits 100 tests cobas e 402/801 true 07957190500 Elecsys AMH Plus en 3 FF00000005071F0E FF000000019B810E 07957190190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve and the prediction of response to controlled ovarian stimulation (COS) in conjunction with other clinical and laboratory findings.In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta of Ferring (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 08818061500 Elecsys AMH Plus en 2 FF00000006C4200E FF000000044C4A0E 08818061190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve and the prediction of response to controlled ovarian stimulation (COS) in conjunction with other clinical and laboratory findings.In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta of Ferring (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 10059524500 Elecsys AMH Plus en 2 FF00000006A2CF0E FF0000000636BB0E 10059524190 10059524214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve, for the prediction of response to controlled ovarian stimulation (COS), to identify polycystic ovarian morphology (PCOM) as an aid in polycystic ovary syndrome (PCOS) diagnosis, and as an aid in diagnosis of Differences of Sex Development (DSD), in conjunction with other clinical and laboratory findings. In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program. Please note that the Elecsys AMH Plus test is not intended to identify patients for treatment with follitropin delta (non-companion diagnostic).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 10059516500 Elecsys AMH Plus en 2 FF00000006A4680E FF0000000653600E 10059516190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve, for the prediction of response to controlled ovarian stimulation (COS), to identify polycystic ovarian morphology (PCOM) as an aid in polycystic ovary syndrome (PCOS) diagnosis, and as an aid in diagnosis of Differences of Sex Development (DSD), in conjunction with other clinical and laboratory findings. In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program. Please note that the Elecsys AMH Plus test is not intended to identify patients for treatment with follitropin delta (non-companion diagnostic).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08818916500 Elecsys AMH Plus en 2 FF00000004750F0E FF00000004750F0E 08818916190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve and the prediction of response to controlled ovarian stimulation (COS) in conjunction with other clinical and laboratory findings.In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta of Ferring (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08818916500 Elecsys AMH Plus en 1 FF000000043D130E FF000000043D130E 08818916190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve and the prediction of response to controlled ovarian stimulation (COS) in conjunction with other clinical and laboratory findings.In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta of Ferring (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07957246500 Elecsys AMH Plus en 4 FF0000000518900E FF00000001B67A0E 07957246190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve and the prediction of response to controlled ovarian stimulation (COS) in conjunction with other clinical and laboratory findings.In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta of Ferring (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en